Patents by Inventor Josiane Eid

Josiane Eid has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods of using an antibody to inhibit WNT-mediated signaling in cancer
    Patent number: 9175090
    Abstract: The present invention is directed to monoclonal antibodies and fragments thereof directed to LRP5/6 that find use in the prevention and treatment of cardiac remodeling and cancer. Also disclosed are methods for using such monoclonal antibodies in the prevention and treatment of such diseases.
    Type: Grant
    Filed: July 29, 2014
    Date of Patent: November 3, 2015
    Assignee: VANDERBILT UNIVERSITY
    Inventors: Ethan Lee, Pampee P. Young, Josiane Eid, Robert Carnahan, Curtis Thorne, Kelly Meyers
  • Methods of using an antibody to inhibit WNT-mediated cardiac remodeling
    Publication number: 20150086540
    Abstract: The present invention is directed to monoclonal antibodies and fragments thereof directed to LRP5/6 that find use in the prevention and treatment of cardiac remodeling and cancer. Also disclosed are methods for using such monoclonal antibodies in the prevention and treatment of such diseases.
    Type: Application
    Filed: July 29, 2014
    Publication date: March 26, 2015
    Applicant: VANDERBILT UNIVERSITY
    Inventors: Ethan LEE, Pampee P. YOUNG, Josiane EID
  • Methods of using an antibody to inhibit WNT-mediated cardiac remodeling
    Patent number: 8790650
    Abstract: The present invention is directed to monoclonal antibodies and fragments thereof directed to LRP5/6 that find use in the prevention and treatment of cardiac remodeling and cancer. Also disclosed are methods for using such monoclonal antibodies in the prevention and treatment of such diseases.
    Type: Grant
    Filed: April 30, 2012
    Date of Patent: July 29, 2014
    Assignee: Vanderbilt University
    Inventors: Ethan Lee, Pampee P. Young, Josiane Eid
  • Antibodies That Inhibit WNT Signaling And Methods Of Using The Same
    Publication number: 20120276089
    Abstract: The present invention is directed to monoclonal antibodies and fragments thereof directed to LRP5/6 that find use in the prevention and treatment of cardiac remodeling and cancer. Also disclosed are methods for using such monoclonal antibodies in the prevention and treatment of such diseases.
    Type: Application
    Filed: April 30, 2012
    Publication date: November 1, 2012
    Inventors: Ethan Lee, Pampee Paul Young, Josiane Eid